Buschke scleredema: A case report
DOI:
https://doi.org/10.66344/jpad.30.1.2020.1471Keywords:
Scleredema of Buschke, scleredemaAbstract
Scleredema is a rare skin disease “progressive hardening of the skin†as the cardinal feature. Here we report a case in a four year old girl with this rare conditionReferences
Martina Huemer,ArnoSeeber, Christian Huemer. Scleroderma-like syndrome in a child: eosinophilic fasciitis or scleredemaadultorum? Eur J Pediatr 2000; 159: 520–522.
Laxer RM, Zulian F. Localized scleroderma. Curr Opin Rheumatol 2006; 18(6): 606-13.
Anja Ulmer, Gundula Schaumburg-Lever, Jens Bauer, Ina Kötter, Gerhard Fierlbeck. Scleroedema adultorum Buschke Fallbericht und Literaturübersicht. Der Hautarzt, 1998; 49(1): 48–54.
Norman N Epstein. Scleredema adultorum (Buschke). J Am Med Assoc 1932; 99(10): 820826.
Yasuji Mori, Veli-Matti Kahari, John Varga. Scleroderma-like cutaneous syndromes. Curr Rheumatol Rep 2002; 4(2): 113-122.
Jennifer Nashel, Virginia Steen Scleroderma mimics. Curr Rheumatol Rep 2011; 14(1): 39-46.
B. Laguda, D. Atherton, J.I. Harper, Misdiagnosis and delay in referral of children with localized scleroderma. Br J Dermatol 2011; 165(6): 1308-1313.
William H Beers, Akgun Ince, Terry L Moore. Scleredema adultorum of Buschke: a case report and review of the literature. Semin Arthritis Rheu 2006; 35(6): 355-9.
M. Tanaka S. Kobayashi Y. Kumagai T. Ebitsuka T. Matsumoto Y. Takasaki H. Hashimoto, Scleredema: report of a case. Mod Rheumatol 2000; 10(1): 51–53.
Downloads
Published
How to Cite
Issue
Section
License
Submission declaration
Authors retain the copyright to their work and grant the 'Journal of Pakistan Association of Dermatologists (JPAD)' the right of first publication under a Creative Commons Attribution 4.0 International (CC BY 4.0) license. This license allows others to share, adapt, and reuse the work for any purpose, including commercial use, as long as appropriate credit is given to the original authors and the journal.
By submitting a manuscript, authors confirm that the work has not been published previously (except as an abstract, lecture, or academic thesis), is not under review elsewhere, and has been approved by all authors and relevant authorities. Once accepted, the article will be openly accessible under the CC BY 4.0 license, ensuring wide dissemination and reuse with proper attribution.